1955•PubMedRequires access

Metabolic inhibitors and nucleotide turnover. I. Inhibition of uptake of radiophosphate in rat liver and hepatoma slices.

William C. Werkheiser, Richard J. Winzler, Donald W. Visser

Open publisher page 9 citations

Abstract

Summary The purine analog, 2,6-diaminopurine, and the pyrimidine nucleoside analog, 5-aminouridine, have been shown to reduce the incorporation of radioactive phosphate into the phospholipids and the ribonucleic acid nucleotides of slices of rat liver and a rat hepatoma. 5-Aminouridine appeared somewhat more effective in liver than in hepatoma, while 2,6-diaminopurine was more effective in hepatoma. Inhibition by aminouridine was nearly uniform in all fractions in both tissues, while that by diaminopurine was greater in the purine nucleotides in liver and in adenylic acid in hepatoma. Differences between the metabolism of liver and hepatoma slices have been observed. Furthermore, purine and pyrimidine analogs have each been shown to inhibit incorporation into both purine and pyrimidine nucleotides, as well as that into phospholipids.

About this research paper

What this paper is about

Summary The purine analog, 2,6-diaminopurine, and the pyrimidine nucleoside analog, 5-aminouridine, have been shown to reduce the incorporation of radioactive phosphate into the phospholipids and the ribonucleic acid nucleotides of slices of rat liver and a rat hepatoma. 5-Aminouridine appeared somewhat more effective in liver than in hepatoma, while 2,6-diaminopurine was more effective in hepatoma. Inhibition by aminouridine was nearly uniform in all fractions in both tissues, while that by diaminopurine was greater in the purine nucleotides in liver and in adenylic acid in hepatoma. Differences between the metabolism of liver and hepatoma slices have been observed. Furthermore, purine and pyrimidine analogs have each been shown to inhibit incorporation into both purine and pyrimidine nucleotides, as well as that into phospholipids.

Why it matters

OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Summary The purine analog, 2,6-diaminopurine, and the pyrimidine nucleoside analog, 5-aminouridine, have been shown to reduce the incorporation of radioactive phosphate into the phospholipids and the ribonucleic acid nucleotides of slices of rat liver and a rat hepatoma. 5-Aminouridine appeared somewhat more effective in liver than in hepatoma, while 2,6-diaminopurine was more effective in hepatoma. Inhibition by aminouridine was nearly uniform in all fractions in both tissues, while that by diaminopurine was greater in the purine nucleotides in liver and in adenylic acid in hepatoma. Differences between the metabolism of liver and hepatoma slices have been observed. Furthermore, purine and pyrimidine analogs have each been shown to inhibit incorporation into both purine and pyrimidine nucleotides, as well as that into phospholipids.

Key concepts: Nucleotide, Purine, Pyrimidine, Purine metabolism, Biochemistry, Pyrimidine metabolism, Nucleoside, Metabolism

Related papers

Back to paper searchBrowse research topicsOriginal source
Metabolic inhibitors and nucleotide turnover. I. Inhibition of uptake of radiophosphate in rat liver and hepatoma slices. — Research Paper | ScholarLens